Additionally, GEPIA39, which uses data from both GTEx and TCGA shows an average of 13.3 TPM for MAP2K4 in cancer and 11.43 TPM for control samples (http://gepia.cancer-pku.cn/detail.php?gene=MAP2K4). Here, MAP2K4 is linked to cancer.